Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenna Thomas

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Medicinal Chemistry|November 16, 2022
Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) FunctionAiste Dobrovolskaite, Holly Moots, Mukund P Tantak, et al.
Cancer|February 13, 2026
The impact of opt-out tobacco screening and treatment referrals among racially and socioeconomically diverse patients in the oncology settingKathryn L Taylor, Julia M Whealan, Kimberly M Davis, et al.
Leukemia & Lymphoma|May 21, 2025
Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 studyBrian T Hill, Pallawi Torka, Francisco Hernandez-Ilizaliturri, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Medicinal Chemistry|November 16, 2022
Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) FunctionAiste Dobrovolskaite, Holly Moots, Mukund P Tantak, et al.
Cancer|February 13, 2026
The impact of opt-out tobacco screening and treatment referrals among racially and socioeconomically diverse patients in the oncology settingKathryn L Taylor, Julia M Whealan, Kimberly M Davis, et al.
Leukemia & Lymphoma|May 21, 2025
Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 studyBrian T Hill, Pallawi Torka, Francisco Hernandez-Ilizaliturri, et al.
Pageof 2